---

---

Corden BioChem GmbH develops, produces and distributes fermentation products and other biochemical or chemical products. The company is a pioneer in the application of green chemistry for intermediates and active pharmaceutical ingredients. For sixty years, Corden BioChem has implemented and optimized large-scale fermentation, downstream, biocatalysis and synthesis processes with world-class efficiency, quality and reliability. The CordenBioChem facility, owned by International Chemical Investors Group (ICIG), serves as a link between CordenPharma's cGMP synthesis capabilities and non-GMP chemical manufacturing at its sister company Weylchem. International Chemical Investors is a private industrial group with sales in excess of EUR 2 billion and over 6,000 employees worldwide. ICIG focuses on three main platforms : Pharmaceuticals under the CordenPharma brand, fine chemicals under the WeylChem brand and Chlorovinyls under the VYNOVA brand.